Troy Cox - May 6, 2021 Form 4 Insider Report for Zymeworks Inc. (ZYME)

Role
Director
Signature
/s/ Daniel Dex, Attorney-in-Fact
Stock symbol
ZYME
Transactions as of
May 6, 2021
Transactions value $
$0
Form type
4
Date filed
5/7/2021, 08:45 PM
Next filing
Sep 3, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZYME Stock Option (Right to Buy) Award $0 +9K $0.00 9K May 6, 2021 Common Shares 9K $29.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options vest on date of next annual general meeting following grant date of May 6, 2021.